About This Educational Activity
Title: You and MDS – An Animated Patient's Guide to Myelodysplastic Syndromes (MDS)
Launch date: July 27, 2018
Title: You and MDS – New Modules on MDS-Related Anemia
Launch date: June 26, 2019
Title: You and MDS – New Module on Understanding Erythropoiesis
Launch date: March 18, 2021
Title: You and MDS – New Modules on Genetic Mutations in MDS, and Mutation-Driven Therapy in MDS
Launch date: June 27, 2022
Title: You and MDS – New Modules on Clinical Trials in MDS
Launch date: December 16, 2024
This educational activity has been designed to meet the educational needs of patients and caregivers affected by Myelodysplastic Syndromes (MDS).
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.
This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.
Faculty:
Dr. Alan F. List, MD
President and CEO, Moffitt Cancer Center and Research Institute
Frank and Carol Morsani Endowed Chair
Tampa, Florida
Dr. Stephen D. Nimer, MD
Director, Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, Florida
Dr. David A. Sallman, MD
Assistant Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida
Dr. Rafael Bejar, MD, PhD
Assistant Professor, Division of Hematology and Oncology
Director, MDS Center of Excellence
University of California San Diego
Moores Cancer Center
La Jolla, California
Dr. Casey L. O’Connell, MD
Associate Professor, Jane Anne Nohl Division of Hematology
University of Southern California
Director, Gehr Cures Myeloid Malignancy Program
Los Angeles, California
Prof. Valeria Santini, MD
Associate Professor, MDS Unit – Hematology
Department of Experimental and Clinical Medicine
University of Florence - AOU Careggi
Florence, Italy
Dr. Dale Schaar, MD, PhD
Associate Professor of Medicine, Division of Medical Oncology
Robert Wood Johnson Medical School
Rutgers, The State University of New Jersey
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
Dr. Amy E. DeZern, MD, MHS
Professor of Oncology
Vice Chair for Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Conflict of Interest Disclosures:
Mechanisms In Medicine Inc. is committed to providing its learners with high quality educational activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this educational activity:
-
Dr. Alan F. List - Consulting fees received from Cellular Biomedicine Group, Celgene, and Jazz Pharma
- Dr. Stephen D. Nimer - Nothing to disclose
- Dr. David A. Sallman - Research funding and speaker fees received from Celgene
- Dr. Rafael Bejar - Salary and stock options from Aptose Biosciences. Consulting fees received from Epizyme, Gilead, and Silence Therapeutics.
- Dr. Casey L. O’Connell – Research funding received from Astex/Otsuka. Consulting fees received from Astex/Otsuka and Pfizer.
- Prof. Valeria Santini – Honoraria from Bristol-Myers Squibb, Geron, Gilead, Novartis, and Takeda.
- Dr. Dale Schaar - Nothing to disclose
- Dr. Amy E. DeZern - Consulting fees received from Celgene/Bristol-Myers Squibb, Agios, Regeneron, Sobi, Novartis, Astellas, and Gilead. Clinical trial committees for Novartis, AbbVie, Kura, Geron, and Celgene/Bristol-Myers Squibb.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance their own personal development.
- The information presented in this activity is not meant to serve as a guideline for patient management.
- Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should be discussed with your physician.
Technical Requirements:
YouAndMDS.com is an internet-based educational program available on Mac and PC. Click
here to view Technical Requirements
